相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder
F. W. Lohoff et al.
PHARMACOGENOMICS JOURNAL (2013)
Pimavanserin, a 5-HT2A receptor inverse agonist, reverses psychosis-like behaviors in a rodent model of Alzheimer's disease
Diana L. Price et al.
BEHAVIOURAL PHARMACOLOGY (2012)
Clinical response to antipsychotic drug treatment: Association study of polymorphisms in six candidate genes
Jelle Vehof et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Off-label uses of trazodone: a review
Letizia Bossini et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
5-HT2 Receptor Distribution Shown by [18F] Setoperone PET in High-Functioning Autistic Adults
David Q. Beversdorf et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2012)
Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [11C]DASB and [18F]altanserin-PET study
Lisbeth Marner et al.
NEUROBIOLOGY OF AGING (2012)
Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: Quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone
Peter S. Talbot et al.
NEUROIMAGE (2012)
Pimavanserin, a selective serotonin (5-HT)2A-inverse agonist, enhances the efficacy and safety of risperidone, 2 mg/day, but does not enhance efficacy of haloperidol, 2 mg/day: Comparison with reference dose risperidone, 6 mg/day
Herbert Y. Meltzer et al.
SCHIZOPHRENIA RESEARCH (2012)
Serotonin 2A receptor antagonists for treatment of schizophrenia
Bjorn H. Ebdrup et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Non-Motor Symptoms of Parkinson's Disease
Klaus Seppi et al.
MOVEMENT DISORDERS (2011)
2.277 OPTIMIZATION OF PHASE III STUDY DESIGN FOR PIMAVANSERIN IN THE TREATMENT OF PARKINSON'S DISEASE PSYCHOSIS (PDP)
R. Mills et al.
PARKINSONISM & RELATED DISORDERS (2011)
The 5-HT2A receptor and serotonin transporter in Asperger's Disorder: A PET study with [11C]MDL 100907 and [11C]DASB
Ragy R. Girgis et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2011)
Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine
Hans Rasmussen et al.
PSYCHOPHARMACOLOGY (2011)
Pimavanserin tartrate, a 5-HT2A receptor inverse agonist, increases slow wave sleep as measured by polysomnography in healthy adult volunteers
Sonia Ancoli-Israel et al.
SLEEP MEDICINE (2011)
Decreased Frontal Serotonin(2A) Receptor Binding in Antipsychotic-Naive Patients With First-Episode Schizophrenia
Hans Rasmussen et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Serotonin 2A Receptors and Visual Hallucinations in Parkinson Disease
Benedicte Ballanger et al.
ARCHIVES OF NEUROLOGY (2010)
Increased 5-HT2A Receptors in the Temporal Cortex of Parkinsonian Patients with Visual Hallucinations
Philippe Huot et al.
MOVEMENT DISORDERS (2010)
Familial Risk for Mood Disorder and the Personality Risk Factor, Neuroticism, Interact in Their Association with Frontolimbic Serotonin 2A Receptor Binding
Vibe G. Frokjaer et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Serotonergic System Genes in Psychosis of Alzheimer Dementia: Meta-Analysis
Seethalakshmi Ramanathan et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2009)
Genetic Variation in the Serotonin 2A Receptor and Suicidal Ideation in a Sample of 270 Irish High-Density Schizophrenia Families
Ayman H. Fanous et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2009)
Candidate gene studies of ADHD: a meta-analytic review
Ian R. Gizer et al.
HUMAN GENETICS (2009)
Brain serotonin 2A receptor binding: Relations to body mass index, tobacco and alcohol use
D. Erritzoe et al.
NEUROIMAGE (2009)
Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy
M. J. V. Wilkie et al.
PHARMACOGENOMICS JOURNAL (2009)
Regional distribution and behavioral correlates of 5-HT2A receptors in Alzheimer's disease with [18F]deuteroaltanserin and PET
Lekshmi Santhosh et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2009)
Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder
Vibe G. Frokjaer et al.
BIOLOGICAL PSYCHIATRY (2008)
Excess of transmission of the G allele of the-1438A/G polymorphism of the 5-HT2A receptor gene in patients with schizophrenia responsive to antipsychotics
Dalila Benmessaoud et al.
BMC PSYCHIATRY (2008)
Serotonin receptors
David E. Nichols et al.
CHEMICAL REVIEWS (2008)
5-HT2A inverse-agonists for the treatment of insomnia
Bradley R. Teegarden et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
Reduced 5-HT2A receptor binding in patients with mild cognitive impairment
S. G. Hasselbalch et al.
NEUROBIOLOGY OF AGING (2008)
In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder
Daniela Perani et al.
NEUROIMAGE (2008)
A 5-HT2A receptor inverse agonist, ACP-103, reduces tremor in a rat model and levodopa-induced dyskinesias in a monkey model
Kimberly E. Vanover et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
Association study between obsessive-compulsive disorder and serotonergic candidate genes
Pilar A. Saiz et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders - First Revision
Borwin Bandelow et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2008)
The association between serotonin-related gene polymorphisms and panic disorder
Ho-Kyoung Yoon et al.
JOURNAL OF ANXIETY DISORDERS (2008)
Prediction of psychosis onset in Alzheimer disease: The role of depression symptom severity and the HTR2A T102C polymorphism
Patricia A. Wilkosz et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)
Serotonergic candidate genes and puerperal psychosis: an association study
H. B. Kiran Kumar et al.
PSYCHIATRIC GENETICS (2007)
Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes
Lorenzo Kiferle et al.
NEUROSCIENCE LETTERS (2007)
Polymorphisms in the serotonin receptor gene HTR2A are associated with quantitative traits in panic disorder
Paul G. Unschuld et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)
Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial
Damiaan Denys et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome
Steven Haugbol et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Analysis of the 5HT-2A T102C receptor polymorphism and psychotic symptoms in Alzheimer's disease
David Craig et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)
Serotonin transporter gene variants and behavior: A comprehensive review
Alessandro Serretti et al.
CURRENT DRUG TARGETS (2006)
Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R, 3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine2A receptor inverse agonist
KE Vanover et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment
FJ McMahon et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Association study of serotonin 2A receptor (5-HT2A) gene with schizophrenia and suicidal behavior using systematic meta-analysis
DW Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Longitudinal assessment of cerebral 5-HT2A receptors in normal volunteers. An [18F]-altanserin PET study
Lisbeth Marner et al.
NEUROIMAGE (2006)
Decreased prefrontal 5-HT2A receptor binding in subjects at enhanced risk for schizophrenia
R Hurlemann et al.
ANATOMY AND EMBRYOLOGY (2005)
Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei
KH Adams et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2005)
Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram
MJ Choi et al.
NEUROPSYCHOBIOLOGY (2005)
Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia
HM Abdolmaleky et al.
SCHIZOPHRENIA RESEARCH (2004)
A database of [18F]-altanserin binding to 5-HT2A receptors in normal volunteers:: normative data and relationship to physiological and demographic variables
KH Adams et al.
NEUROIMAGE (2004)
Decreased hippocampal 5-HT2A receptor binding in major depressive disorder:: In vivo measurement with [18F]Altanserin positron emission tomography
MA Mintun et al.
BIOLOGICAL PSYCHIATRY (2004)
Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia
AL López-Figueroa et al.
BIOLOGICAL PSYCHIATRY (2004)
Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease
F Assal et al.
ARCHIVES OF NEUROLOGY (2004)
Increased mRNA expression of α2A-adrenoceptors, serotonin receptors and μ-opioid receptors in the brains of suicide victims
PV Escribá et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Decreased hippocampal 5-HT2A receptor binding in older depressed patients using [18F] altanserin positron emission tomography
YI Sheline et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Long-term outcome of clozapine use for psychosis in parkinsonian patients
HH Fernandez et al.
MOVEMENT DISORDERS (2004)
Are the cognitive effects of atypical antipsychotics influenced by their affinity to 5HT-2A receptors?
PJ Tyson et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2004)
Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and Schizoaffective disorder
HY Meltzer et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Altered 5-HT2A receptor binding after recovery from bulimia-type anorexia nervosa:: Relationships to harm avoidance and drive for thinness
UF Bailer et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Clozapine in drug induced psychosis in Parkinson's disease:: a randomised, placebo controlled study with open follow up
P Pollak et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
Depression in Alzheimer's disease: The effect of serotonin receptor gene variation
C Holmes et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2003)
Serotoninergic polymorphisms (5-HTTLPR and 5-HT2A): Association studies with psychosis in Alzheimer disease
A Rocchi et al.
GENETIC TESTING (2003)
A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders
M Anguelova et al.
MOLECULAR PSYCHIATRY (2003)
A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior
M Anguelova et al.
MOLECULAR PSYCHIATRY (2003)
Reduced 5-HT2A receptor binding after recovery from anorexia nervosa
GK Frank et al.
BIOLOGICAL PSYCHIATRY (2002)
5-HT2A gene promoter polymorphism as a modifying rather than a vulnerability factor in anorexia nervosa
A Kipman et al.
EUROPEAN PSYCHIATRY (2002)
Differential expression of the C and T alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics
OO Polesskaya et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Higher expression of serotonin 5-HT2A receptors in the postmortem brains of teenage suicide victims
GN Pandey et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Association between-1438G/A promoter polymorphism in the 5-HT2A receptor gene and fluvoxamine response in Japanese patients with major depressive disorder
K Sato et al.
NEUROPSYCHOBIOLOGY (2002)
Association between 5-HT2A receptor polymorphism and psychotic symptoms in Alzheimer's disease
B Nacmias et al.
BIOLOGICAL PSYCHIATRY (2001)
Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia
VS Basile et al.
MOLECULAR PSYCHIATRY (2001)
Decreased frontal serotonin 5-HT2a receptor binding index in deliberate self-harm patients
K Audenaert et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)
A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT2A receptor changes in schizophrenia
NPLG Verhoeff et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2000)
分享论文
